Table 2.
Infection | Candidate gene region | Main function of protein encoded | Selected references |
---|---|---|---|
HIV and AIDS | CCR5, CCR2 | Chemokine receptor | Carrington et al,12 Martin et al18 |
HLA class I | Antigen presentation | ||
Hepatitis B | HLA class II | Antigen presentation | Thursz et al13 |
Meningococcal disease | C5 to C9 | Terminal complement pathway | Hibberd et al19 |
MBL | Opsonisation | ||
Tuberculosis | HLA-DR | Antigen presentation | Singh et al,11 Bellamy et al20 |
NRAMP1 | Divalent cation transporter | ||
VDR | Vitamin D receptor | ||
Leprosy | HLA class II | Antigen presentation | Todd et al,21 Roy et al22 |
TNF | Pro-inflammatory cytokine | ||
Malaria | DARC | Chemokine receptor | Hill et al,10 Knight et al,15 Miller et al,23 Tournamille et al,24 Flint et al,25 Ruwende et al26 |
α and β globin | Haemoglobin subunits | ||
G6PD | Carbohydrate metabolism | ||
HLA class I and II | Antigen presentation | ||
TNF | Pro-inflammatory cytokine | ||
Leishmaniasis | TNF | Pro-inflammatory cytokine | Cabrera et al27 |
Gene regions in which allelic variants have been associated with increased or decreased susceptibility to infectious disease. Variant allele is often common in the population (such as above 10%), but alteration in disease risk is relatively modest (twofold to fourfold). These examples probably represent a small minority of the total number of genetic factors involved.